American Journal of Cancer Prevention
ISSN (Print): 2328-7314 ISSN (Online): 2328-7322 Website: http://www.sciepub.com/journal/ajcp Editor-in-chief: Nabil Abdel-Hamid
Open Access
Journal Browser
Go

Special Issue "Treatment Cases for Hematological Malignancies"

A special issue of American Journal of Cancer Prevention (ISSN 2328-7322 ).

Special Issue Editors

Chief Guest Editor

Dr Mehrdad Payandeh
Cancer Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
Email: md.payandeh@yahoo.com

Guest Editor

Dr. Masoud Sadeghi
Cancer Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
Email: sadeghi_mbrc@yahoo.com

Mr Edris Sadeghi
Cancer Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
Email: sadeghi_mkn@yahoo.com

Special Issue Information

Hematologic malignancies are cancers of the blood. These cancers manifest themselves in ways that affect blood, bone marrow and lymph nodes. Because blood, bone marrow and lymph nodes are so completely interconnected, diseases that affect one may lead to the spread of disease to other related sites. Some types of hematologic malignancies include: Leukemia, Non-Hodgkin lymphoma, Hodgkin lymphoma, Multiple myeloma. Due to the wide range of hematological malignancies, there are also many ways to treat blood cancers. From chemotherapy, radiotherapy, targeted therapy, immunotherapy to bone marrow transplants, Wellness Oncology & Hematology has the medical expertise to diagnose and customize a treatment plan to combat the spread of disease, providing the best chance of remission and cure. Our main goal is to express new therapies, especially in the field of new drugs.

Special Issue Topics

About the issue

The scope of topics covered in the this issue include:

  • 1. Rare case
  • 2. new drug
  • 3. Complete Response
  • 4. Bone Marrow Transplantation
  • 5. Genetic
  • 6. Immunotherapy

Import Dates & Submit

Important dates

Submission Deadline: September 05, 2017
Notification of Acceptance: September 15, 2017
Final Version Due: September 20, 2017
Special Issue Publishing Date: September 28, 2017

Submit your article now

Manuscripts should be submitted as an attached file to an e-mail directed to the Chief Guest Editor, Dr Mehrdad Payandeh at the address: <md.payandeh@yahoo.com>

Published Papers (6 Papers)

Open AccessReview Article
Special Issue
American Journal of Cancer Prevention. 2017, 5(3), 34-34. DOI: 10.12691/ajcp-5-3-1
Pub. Date: October 10, 2017
Open AccessResearch Article
Mycosis Fungoides: A Case Report
American Journal of Cancer Prevention. 2017, 5(3), 35-36. DOI: 10.12691/ajcp-5-3-2
Pub. Date: October 10, 2017
This article belongs to the Special Issue Treatment Cases for Hematological Malignancies
Open AccessResearch Article
Two Different Faces from Unicentric Castleman Disease (UCD): A Case Series
American Journal of Cancer Prevention. 2017, 5(3), 37-38. DOI: 10.12691/ajcp-5-3-3
Pub. Date: October 10, 2017
This article belongs to the Special Issue Treatment Cases for Hematological Malignancies
Open AccessResearch Article
Brentuximab for Refactory Hodgkin’s Lymphoma: A Case Report
American Journal of Cancer Prevention. 2017, 5(3), 39-40. DOI: 10.12691/ajcp-5-3-4
Pub. Date: October 10, 2017
This article belongs to the Special Issue Treatment Cases for Hematological Malignancies
Open AccessResearch Article
The role of 18F-FDG PET/CT in Better Follow up in Patient with Hodgkin Lymphoma: A Case Report
American Journal of Cancer Prevention. 2017, 5(3), 41-43. DOI: 10.12691/ajcp-5-3-5
Pub. Date: October 10, 2017
This article belongs to the Special Issue Treatment Cases for Hematological Malignancies
Figure of 1
Open AccessResearch Article
The Efficacy of Ibrutinib in Two Patients with Chronic Lymphocytic Leukemia: A Case Report
American Journal of Cancer Prevention. 2017, 5(3), 44-45. DOI: 10.12691/ajcp-5-3-6
Pub. Date: October 10, 2017
This article belongs to the Special Issue Treatment Cases for Hematological Malignancies